AstraZeneca
AstraZeneca beats third-quarter expectations, maintains outlook
The firm will also list its shares on the NYSE to gain access to a deeper capital pool
AstraZeneca quarterly net profit jumps on record US growth
Profit after tax rose to US$2.45 billion in the three months to the end of June
AstraZeneca vows to spend US$50 billion on US manufacturing, development
President Donald Trump has proposed various timelines for tariffs on pharmaceuticals, most recently floating duties that would be imposed as soon as Aug 1
AstraZeneca seeks to move past China probe with Beijing R&D hub
The new R&D centre represents CEO Pascal Soriot doubling down on a key market in which his company has already invested heavily
AstraZeneca invests US$2.5 billion in Beijing, undeterred by probe
The hub will focus on early-stage research and include an artificial intelligence lab
AstraZeneca to buy EsoBiotec for up to US$1 billion
AstraZeneca will buy all outstanding equity of EsoBiotec for on a cash and debt-free basis
AstraZeneca cancels UK plant after subsidies cut
BRITISH pharmaceutical giant AstraZeneca said on Friday (Jan 31) that it was abandoning plans to build a £450 million (S$756.9 million) vaccine plant, a major blow to the Labour government’s plans to ...
Beijing woos AstraZeneca for investment while probe continues
BEIJING’S mayor called on AstraZeneca to expand its research and development investment in the Chinese capital, signalling that a probe against some of its executives will not affect business ties wit...
AstraZeneca lifts 2024 revenue and profit forecast after Q3 beat
DRUGMAKER AstraZeneca lifted its annual sales and profit forecast for the second time in less than four months on Tuesday (Nov 12), helped by resilient demand for its cancer and rare diseases medicine...
AstraZeneca’s US$1.5 billion manufacturing plant to create over 800 jobs in Singapore
This is the biopharmaceutical multinational’s largest to date in terms of initial build investment
